nodes	percent_of_prediction	percent_of_DWPC	metapath
Ruxolitinib—BMP2K—synovial membrane of synovial joint—osteoarthritis	0.024	0.175	CbGeAlD
Ruxolitinib—PRKCE—tendon—osteoarthritis	0.0079	0.0575	CbGeAlD
Ruxolitinib—RPS6KA6—tendon—osteoarthritis	0.00759	0.0553	CbGeAlD
Ruxolitinib—CAMK1—tendon—osteoarthritis	0.00592	0.0432	CbGeAlD
Ruxolitinib—MARK2—tendon—osteoarthritis	0.00575	0.0419	CbGeAlD
Ruxolitinib—TAOK2—tendon—osteoarthritis	0.00532	0.0388	CbGeAlD
Ruxolitinib—JAK1—tendon—osteoarthritis	0.00486	0.0354	CbGeAlD
Ruxolitinib—DCLK1—tendon—osteoarthritis	0.00486	0.0354	CbGeAlD
Ruxolitinib—CAMK1D—tendon—osteoarthritis	0.00474	0.0346	CbGeAlD
Ruxolitinib—PHKG2—tendon—osteoarthritis	0.00472	0.0344	CbGeAlD
Ruxolitinib—DAPK2—tendon—osteoarthritis	0.00464	0.0338	CbGeAlD
Ruxolitinib—STK16—tendon—osteoarthritis	0.00456	0.0332	CbGeAlD
Ruxolitinib—HIPK2—tendon—osteoarthritis	0.00454	0.033	CbGeAlD
Ruxolitinib—DAPK3—tendon—osteoarthritis	0.00436	0.0318	CbGeAlD
Ruxolitinib—CLK2—tendon—osteoarthritis	0.00432	0.0315	CbGeAlD
Ruxolitinib—BMPR2—tendon—osteoarthritis	0.00407	0.0296	CbGeAlD
Ruxolitinib—CAMK2G—tendon—osteoarthritis	0.00364	0.0265	CbGeAlD
Ruxolitinib—BMP2K—tendon—osteoarthritis	0.00364	0.0265	CbGeAlD
Ruxolitinib—LRRK2—tendon—osteoarthritis	0.00361	0.0263	CbGeAlD
Ruxolitinib—MAP3K7—tendon—osteoarthritis	0.00327	0.0238	CbGeAlD
Ruxolitinib—TYK2—tendon—osteoarthritis	0.00321	0.0234	CbGeAlD
Ruxolitinib—MKNK2—tendon—osteoarthritis	0.00317	0.0231	CbGeAlD
Ruxolitinib—IRAK1—tendon—osteoarthritis	0.00317	0.0231	CbGeAlD
Ruxolitinib—RET—tendon—osteoarthritis	0.00309	0.0225	CbGeAlD
Ruxolitinib—JAK2—tendon—osteoarthritis	0.00292	0.0213	CbGeAlD
Ruxolitinib—MAP3K3—tendon—osteoarthritis	0.00282	0.0205	CbGeAlD
Ruxolitinib—TAOK3—tendon—osteoarthritis	0.00257	0.0187	CbGeAlD
Ruxolitinib—TYK2—Signaling by FGFR in disease—IL6—osteoarthritis	0.000131	0.000151	CbGpPWpGaD
Ruxolitinib—TYK2—Fc epsilon receptor (FCERI) signaling—IL6—osteoarthritis	0.000131	0.000151	CbGpPWpGaD
Ruxolitinib—TYK2—DAP12 interactions—IL6—osteoarthritis	0.000131	0.000151	CbGpPWpGaD
Ruxolitinib—MAP3K7—Immune System—IL1RN—osteoarthritis	0.00013	0.000151	CbGpPWpGaD
Ruxolitinib—TYK2—Axon guidance—MMP9—osteoarthritis	0.00013	0.00015	CbGpPWpGaD
Ruxolitinib—TYK2—Signaling by EGFR—IL6—osteoarthritis	0.000129	0.00015	CbGpPWpGaD
Ruxolitinib—JAK1—Signaling Pathways—BMP2—osteoarthritis	0.000129	0.00015	CbGpPWpGaD
Ruxolitinib—TYK2—Signaling by EGFR in Cancer—IL6—osteoarthritis	0.000128	0.000149	CbGpPWpGaD
Ruxolitinib—TYK2—Signaling by PDGF—IL6—osteoarthritis	0.000128	0.000148	CbGpPWpGaD
Ruxolitinib—JAK3—Immune System—CRP—osteoarthritis	0.000127	0.000148	CbGpPWpGaD
Ruxolitinib—ROCK1—Signaling Pathways—BMP2—osteoarthritis	0.000127	0.000147	CbGpPWpGaD
Ruxolitinib—MAP3K7—Fc epsilon receptor (FCERI) signaling—IL6—osteoarthritis	0.000127	0.000147	CbGpPWpGaD
Ruxolitinib—JAK1—Developmental Biology—MMP9—osteoarthritis	0.000125	0.000145	CbGpPWpGaD
Ruxolitinib—PRKCE—Signaling Pathways—MMP3—osteoarthritis	0.000123	0.000143	CbGpPWpGaD
Ruxolitinib—ROCK1—Developmental Biology—MMP9—osteoarthritis	0.000123	0.000143	CbGpPWpGaD
Ruxolitinib—TYK2—Developmental Biology—MMP2—osteoarthritis	0.000123	0.000143	CbGpPWpGaD
Ruxolitinib—JAK1—Cytokine Signaling in Immune system—IL6—osteoarthritis	0.000123	0.000142	CbGpPWpGaD
Ruxolitinib—BMPR2—Signaling Pathways—IGF1—osteoarthritis	0.000122	0.000141	CbGpPWpGaD
Ruxolitinib—PHKG2—Metabolism—PTGS2—osteoarthritis	0.000121	0.00014	CbGpPWpGaD
Ruxolitinib—JAK1—Signaling by NGF—IL6—osteoarthritis	0.000121	0.00014	CbGpPWpGaD
Ruxolitinib—JAK2—Toll-Like Receptors Cascades—IL6—osteoarthritis	0.000119	0.000138	CbGpPWpGaD
Ruxolitinib—JAK2—Signaling by SCF-KIT—IL6—osteoarthritis	0.000119	0.000138	CbGpPWpGaD
Ruxolitinib—PRKCE—GPCR downstream signaling—CXCL8—osteoarthritis	0.000118	0.000137	CbGpPWpGaD
Ruxolitinib—JAK2—Hemostasis—MMP1—osteoarthritis	0.000118	0.000137	CbGpPWpGaD
Ruxolitinib—JAK3—Hemostasis—TGFB1—osteoarthritis	0.000118	0.000137	CbGpPWpGaD
Ruxolitinib—JAK2—Cytokine Signaling in Immune system—IL1B—osteoarthritis	0.000117	0.000136	CbGpPWpGaD
Ruxolitinib—JAK2—Developmental Biology—LEP—osteoarthritis	0.000117	0.000135	CbGpPWpGaD
Ruxolitinib—JAK1—Disease—SMAD3—osteoarthritis	0.000116	0.000134	CbGpPWpGaD
Ruxolitinib—TYK2—NGF signalling via TRKA from the plasma membrane—IL6—osteoarthritis	0.000116	0.000134	CbGpPWpGaD
Ruxolitinib—GRK1—Disease—TGFB1—osteoarthritis	0.000115	0.000133	CbGpPWpGaD
Ruxolitinib—PRKG2—Signaling Pathways—CXCL8—osteoarthritis	0.000115	0.000133	CbGpPWpGaD
Ruxolitinib—JAK2—Downstream signaling of activated FGFR—IL6—osteoarthritis	0.000114	0.000132	CbGpPWpGaD
Ruxolitinib—TYK2—Signaling by GPCR—MMP3—osteoarthritis	0.000112	0.00013	CbGpPWpGaD
Ruxolitinib—JAK2—Signaling by ERBB4—IL6—osteoarthritis	0.000112	0.00013	CbGpPWpGaD
Ruxolitinib—TYK2—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—osteoarthritis	0.000112	0.00013	CbGpPWpGaD
Ruxolitinib—PRKCE—Signaling Pathways—SMAD3—osteoarthritis	0.000112	0.00013	CbGpPWpGaD
Ruxolitinib—JAK2—Platelet activation, signaling and aggregation—TGFB1—osteoarthritis	0.00011	0.000128	CbGpPWpGaD
Ruxolitinib—JAK1—Immune System—CRP—osteoarthritis	0.00011	0.000127	CbGpPWpGaD
Ruxolitinib—JAK1—Axon guidance—IL6—osteoarthritis	0.000109	0.000126	CbGpPWpGaD
Ruxolitinib—JAK2—Signaling Pathways—COL9A2—osteoarthritis	0.000109	0.000126	CbGpPWpGaD
Ruxolitinib—GRK1—Signaling Pathways—CXCL8—osteoarthritis	0.000108	0.000125	CbGpPWpGaD
Ruxolitinib—JAK2—Hemostasis—FN1—osteoarthritis	0.000108	0.000125	CbGpPWpGaD
Ruxolitinib—PRKCE—Signaling by GPCR—CXCL8—osteoarthritis	0.000107	0.000125	CbGpPWpGaD
Ruxolitinib—ROCK1—Axon guidance—IL6—osteoarthritis	0.000107	0.000124	CbGpPWpGaD
Ruxolitinib—JAK2—Downstream signal transduction—IL6—osteoarthritis	0.000107	0.000124	CbGpPWpGaD
Ruxolitinib—JAK2—Signaling by FGFR—IL6—osteoarthritis	0.000106	0.000123	CbGpPWpGaD
Ruxolitinib—JAK2—Signaling by ERBB2—IL6—osteoarthritis	0.000106	0.000123	CbGpPWpGaD
Ruxolitinib—JAK2—Signaling Pathways—COL9A1—osteoarthritis	0.000106	0.000122	CbGpPWpGaD
Ruxolitinib—JAK2—Innate Immune System—CRP—osteoarthritis	0.000105	0.000122	CbGpPWpGaD
Ruxolitinib—JAK2—DAP12 signaling—IL6—osteoarthritis	0.000105	0.000122	CbGpPWpGaD
Ruxolitinib—JAK2—Immune System—HSPA5—osteoarthritis	0.000105	0.000121	CbGpPWpGaD
Ruxolitinib—JAK3—Signaling Pathways—MMP3—osteoarthritis	0.000104	0.000121	CbGpPWpGaD
Ruxolitinib—PHKG2—Disease—TGFB1—osteoarthritis	0.000104	0.000121	CbGpPWpGaD
Ruxolitinib—PRKG2—Signaling Pathways—MMP9—osteoarthritis	0.000104	0.000121	CbGpPWpGaD
Ruxolitinib—JAK1—Developmental Biology—TGFB1—osteoarthritis	0.000103	0.00012	CbGpPWpGaD
Ruxolitinib—JAK2—Immune System—IL1RN—osteoarthritis	0.000102	0.000118	CbGpPWpGaD
Ruxolitinib—ROCK1—Developmental Biology—TGFB1—osteoarthritis	0.000102	0.000118	CbGpPWpGaD
Ruxolitinib—JAK1—Hemostasis—TGFB1—osteoarthritis	0.000101	0.000117	CbGpPWpGaD
Ruxolitinib—JAK3—GPCR downstream signaling—CXCL8—osteoarthritis	9.99e-05	0.000116	CbGpPWpGaD
Ruxolitinib—IRAK1—Immune System—IL1A—osteoarthritis	9.97e-05	0.000116	CbGpPWpGaD
Ruxolitinib—JAK2—Signaling by FGFR in disease—IL6—osteoarthritis	9.9e-05	0.000115	CbGpPWpGaD
Ruxolitinib—JAK2—DAP12 interactions—IL6—osteoarthritis	9.9e-05	0.000115	CbGpPWpGaD
Ruxolitinib—JAK2—Fc epsilon receptor (FCERI) signaling—IL6—osteoarthritis	9.9e-05	0.000115	CbGpPWpGaD
Ruxolitinib—IRAK1—Signaling Pathways—BMP2—osteoarthritis	9.84e-05	0.000114	CbGpPWpGaD
Ruxolitinib—JAK2—Axon guidance—MMP9—osteoarthritis	9.83e-05	0.000114	CbGpPWpGaD
Ruxolitinib—JAK2—Signaling by EGFR—IL6—osteoarthritis	9.81e-05	0.000114	CbGpPWpGaD
Ruxolitinib—GRK1—Signaling Pathways—MMP9—osteoarthritis	9.78e-05	0.000113	CbGpPWpGaD
Ruxolitinib—BMPR2—Signaling Pathways—CXCL8—osteoarthritis	9.78e-05	0.000113	CbGpPWpGaD
Ruxolitinib—JAK2—Signaling by EGFR in Cancer—IL6—osteoarthritis	9.73e-05	0.000113	CbGpPWpGaD
Ruxolitinib—JAK2—Signaling by PDGF—IL6—osteoarthritis	9.68e-05	0.000112	CbGpPWpGaD
Ruxolitinib—TYK2—Immune System—IL1A—osteoarthritis	9.68e-05	0.000112	CbGpPWpGaD
Ruxolitinib—JAK1—Developmental Biology—TNF—osteoarthritis	9.65e-05	0.000112	CbGpPWpGaD
Ruxolitinib—PRKCE—Signaling Pathways—LEP—osteoarthritis	9.55e-05	0.000111	CbGpPWpGaD
Ruxolitinib—TYK2—Signaling Pathways—BMP2—osteoarthritis	9.55e-05	0.000111	CbGpPWpGaD
Ruxolitinib—ROCK1—Developmental Biology—TNF—osteoarthritis	9.49e-05	0.00011	CbGpPWpGaD
Ruxolitinib—PRKCE—Innate Immune System—IL6—osteoarthritis	9.47e-05	0.00011	CbGpPWpGaD
Ruxolitinib—JAK2—Hemostasis—IGF1—osteoarthritis	9.46e-05	0.00011	CbGpPWpGaD
Ruxolitinib—JAK3—Signaling Pathways—SMAD3—osteoarthritis	9.43e-05	0.000109	CbGpPWpGaD
Ruxolitinib—PRKCE—Immune System—IL1B—osteoarthritis	9.42e-05	0.000109	CbGpPWpGaD
Ruxolitinib—MAP3K7—Immune System—IL1A—osteoarthritis	9.39e-05	0.000109	CbGpPWpGaD
Ruxolitinib—PRKCE—Disease—PTGS2—osteoarthritis	9.35e-05	0.000108	CbGpPWpGaD
Ruxolitinib—JAK2—Developmental Biology—MMP2—osteoarthritis	9.33e-05	0.000108	CbGpPWpGaD
Ruxolitinib—IRAK1—Cytokine Signaling in Immune system—IL6—osteoarthritis	9.32e-05	0.000108	CbGpPWpGaD
Ruxolitinib—MAP3K7—Signaling Pathways—BMP2—osteoarthritis	9.26e-05	0.000107	CbGpPWpGaD
Ruxolitinib—TYK2—Developmental Biology—MMP9—osteoarthritis	9.25e-05	0.000107	CbGpPWpGaD
Ruxolitinib—IRAK1—Signaling by NGF—IL6—osteoarthritis	9.17e-05	0.000106	CbGpPWpGaD
Ruxolitinib—PRKCE—Signaling Pathways—ESR1—osteoarthritis	9.12e-05	0.000106	CbGpPWpGaD
Ruxolitinib—JAK3—Signaling by GPCR—CXCL8—osteoarthritis	9.07e-05	0.000105	CbGpPWpGaD
Ruxolitinib—TYK2—Cytokine Signaling in Immune system—IL6—osteoarthritis	9.05e-05	0.000105	CbGpPWpGaD
Ruxolitinib—PRKCE—Signaling Pathways—FN1—osteoarthritis	9.01e-05	0.000104	CbGpPWpGaD
Ruxolitinib—JAK1—Signaling Pathways—MMP3—osteoarthritis	8.97e-05	0.000104	CbGpPWpGaD
Ruxolitinib—TYK2—Signaling by NGF—IL6—osteoarthritis	8.9e-05	0.000103	CbGpPWpGaD
Ruxolitinib—BMPR2—Signaling Pathways—MMP9—osteoarthritis	8.84e-05	0.000103	CbGpPWpGaD
Ruxolitinib—ROCK1—Signaling Pathways—MMP3—osteoarthritis	8.82e-05	0.000102	CbGpPWpGaD
Ruxolitinib—MAP3K7—Cytokine Signaling in Immune system—IL6—osteoarthritis	8.78e-05	0.000102	CbGpPWpGaD
Ruxolitinib—JAK2—NGF signalling via TRKA from the plasma membrane—IL6—osteoarthritis	8.77e-05	0.000102	CbGpPWpGaD
Ruxolitinib—GRK1—Disease—IL6—osteoarthritis	8.67e-05	0.000101	CbGpPWpGaD
Ruxolitinib—CAMK2G—Immune System—IL1B—osteoarthritis	8.63e-05	0.0001	CbGpPWpGaD
Ruxolitinib—JAK1—GPCR downstream signaling—CXCL8—osteoarthritis	8.59e-05	9.96e-05	CbGpPWpGaD
Ruxolitinib—PRKG2—Signaling Pathways—TGFB1—osteoarthritis	8.57e-05	9.94e-05	CbGpPWpGaD
Ruxolitinib—TYK2—Disease—SMAD3—osteoarthritis	8.55e-05	9.92e-05	CbGpPWpGaD
Ruxolitinib—JAK2—Signaling by GPCR—MMP3—osteoarthritis	8.49e-05	9.84e-05	CbGpPWpGaD
Ruxolitinib—JAK2—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—osteoarthritis	8.47e-05	9.82e-05	CbGpPWpGaD
Ruxolitinib—ROCK1—GPCR downstream signaling—CXCL8—osteoarthritis	8.45e-05	9.8e-05	CbGpPWpGaD
Ruxolitinib—MAP3K3—Immune System—IL1B—osteoarthritis	8.43e-05	9.77e-05	CbGpPWpGaD
Ruxolitinib—IRAK1—Immune System—CRP—osteoarthritis	8.34e-05	9.66e-05	CbGpPWpGaD
Ruxolitinib—JAK1—Signaling Pathways—SMAD3—osteoarthritis	8.11e-05	9.41e-05	CbGpPWpGaD
Ruxolitinib—TYK2—Immune System—CRP—osteoarthritis	8.09e-05	9.38e-05	CbGpPWpGaD
Ruxolitinib—JAK3—Signaling Pathways—LEP—osteoarthritis	8.06e-05	9.35e-05	CbGpPWpGaD
Ruxolitinib—GRK1—Signaling Pathways—TGFB1—osteoarthritis	8.06e-05	9.34e-05	CbGpPWpGaD
Ruxolitinib—TYK2—Axon guidance—IL6—osteoarthritis	8.05e-05	9.34e-05	CbGpPWpGaD
Ruxolitinib—ROCK1—Signaling Pathways—SMAD3—osteoarthritis	7.98e-05	9.25e-05	CbGpPWpGaD
Ruxolitinib—JAK3—Immune System—IL1B—osteoarthritis	7.95e-05	9.21e-05	CbGpPWpGaD
Ruxolitinib—PRKCE—Signaling Pathways—IGF1—osteoarthritis	7.89e-05	9.15e-05	CbGpPWpGaD
Ruxolitinib—MAP3K7—Immune System—CRP—osteoarthritis	7.85e-05	9.1e-05	CbGpPWpGaD
Ruxolitinib—PHKG2—Disease—IL6—osteoarthritis	7.84e-05	9.09e-05	CbGpPWpGaD
Ruxolitinib—JAK1—Signaling by GPCR—CXCL8—osteoarthritis	7.8e-05	9.04e-05	CbGpPWpGaD
Ruxolitinib—JAK1—Developmental Biology—IL6—osteoarthritis	7.79e-05	9.02e-05	CbGpPWpGaD
Ruxolitinib—JAK3—Signaling Pathways—ESR1—osteoarthritis	7.7e-05	8.92e-05	CbGpPWpGaD
Ruxolitinib—ROCK1—Signaling by GPCR—CXCL8—osteoarthritis	7.67e-05	8.9e-05	CbGpPWpGaD
Ruxolitinib—ROCK1—Developmental Biology—IL6—osteoarthritis	7.66e-05	8.88e-05	CbGpPWpGaD
Ruxolitinib—TYK2—Developmental Biology—TGFB1—osteoarthritis	7.63e-05	8.84e-05	CbGpPWpGaD
Ruxolitinib—JAK3—Signaling Pathways—FN1—osteoarthritis	7.6e-05	8.81e-05	CbGpPWpGaD
Ruxolitinib—JAK2—Immune System—IL1A—osteoarthritis	7.34e-05	8.5e-05	CbGpPWpGaD
Ruxolitinib—BMPR2—Signaling Pathways—TGFB1—osteoarthritis	7.29e-05	8.45e-05	CbGpPWpGaD
Ruxolitinib—JAK2—Signaling Pathways—BMP2—osteoarthritis	7.24e-05	8.39e-05	CbGpPWpGaD
Ruxolitinib—TYK2—Developmental Biology—TNF—osteoarthritis	7.12e-05	8.26e-05	CbGpPWpGaD
Ruxolitinib—JAK2—Developmental Biology—MMP9—osteoarthritis	7.01e-05	8.13e-05	CbGpPWpGaD
Ruxolitinib—JAK1—Signaling Pathways—LEP—osteoarthritis	6.94e-05	8.04e-05	CbGpPWpGaD
Ruxolitinib—JAK1—Innate Immune System—IL6—osteoarthritis	6.88e-05	7.97e-05	CbGpPWpGaD
Ruxolitinib—JAK2—Cytokine Signaling in Immune system—IL6—osteoarthritis	6.86e-05	7.95e-05	CbGpPWpGaD
Ruxolitinib—JAK1—Immune System—IL1B—osteoarthritis	6.84e-05	7.93e-05	CbGpPWpGaD
Ruxolitinib—ROCK1—Signaling Pathways—LEP—osteoarthritis	6.82e-05	7.91e-05	CbGpPWpGaD
Ruxolitinib—IRAK1—Signaling Pathways—MMP3—osteoarthritis	6.82e-05	7.9e-05	CbGpPWpGaD
Ruxolitinib—JAK1—Disease—PTGS2—osteoarthritis	6.79e-05	7.87e-05	CbGpPWpGaD
Ruxolitinib—PRKCE—Disease—TGFB1—osteoarthritis	6.76e-05	7.83e-05	CbGpPWpGaD
Ruxolitinib—JAK2—Signaling by NGF—IL6—osteoarthritis	6.74e-05	7.82e-05	CbGpPWpGaD
Ruxolitinib—JAK3—Signaling Pathways—IGF1—osteoarthritis	6.66e-05	7.72e-05	CbGpPWpGaD
Ruxolitinib—JAK1—Signaling Pathways—ESR1—osteoarthritis	6.62e-05	7.68e-05	CbGpPWpGaD
Ruxolitinib—TYK2—Signaling Pathways—MMP3—osteoarthritis	6.62e-05	7.67e-05	CbGpPWpGaD
Ruxolitinib—JAK1—Signaling Pathways—FN1—osteoarthritis	6.54e-05	7.58e-05	CbGpPWpGaD
Ruxolitinib—ROCK1—Signaling Pathways—ESR1—osteoarthritis	6.51e-05	7.55e-05	CbGpPWpGaD
Ruxolitinib—JAK2—Disease—SMAD3—osteoarthritis	6.48e-05	7.51e-05	CbGpPWpGaD
Ruxolitinib—PRKG2—Signaling Pathways—IL6—osteoarthritis	6.46e-05	7.49e-05	CbGpPWpGaD
Ruxolitinib—ROCK1—Signaling Pathways—FN1—osteoarthritis	6.43e-05	7.46e-05	CbGpPWpGaD
Ruxolitinib—MAP3K7—Signaling Pathways—MMP3—osteoarthritis	6.42e-05	7.44e-05	CbGpPWpGaD
Ruxolitinib—PRKCE—Signaling Pathways—CXCL8—osteoarthritis	6.35e-05	7.36e-05	CbGpPWpGaD
Ruxolitinib—IRAK1—Signaling Pathways—SMAD3—osteoarthritis	6.17e-05	7.15e-05	CbGpPWpGaD
Ruxolitinib—JAK2—Immune System—CRP—osteoarthritis	6.13e-05	7.11e-05	CbGpPWpGaD
Ruxolitinib—JAK2—Axon guidance—IL6—osteoarthritis	6.1e-05	7.08e-05	CbGpPWpGaD
Ruxolitinib—GRK1—Signaling Pathways—IL6—osteoarthritis	6.07e-05	7.04e-05	CbGpPWpGaD
Ruxolitinib—PRKCE—Signaling by GPCR—IL6—osteoarthritis	6.04e-05	7e-05	CbGpPWpGaD
Ruxolitinib—TYK2—Signaling Pathways—SMAD3—osteoarthritis	5.99e-05	6.94e-05	CbGpPWpGaD
Ruxolitinib—MAP3K7—Signaling Pathways—SMAD3—osteoarthritis	5.81e-05	6.73e-05	CbGpPWpGaD
Ruxolitinib—JAK2—Developmental Biology—TGFB1—osteoarthritis	5.78e-05	6.7e-05	CbGpPWpGaD
Ruxolitinib—TYK2—Signaling by GPCR—CXCL8—osteoarthritis	5.76e-05	6.68e-05	CbGpPWpGaD
Ruxolitinib—TYK2—Developmental Biology—IL6—osteoarthritis	5.75e-05	6.66e-05	CbGpPWpGaD
Ruxolitinib—PRKCE—Signaling Pathways—MMP9—osteoarthritis	5.74e-05	6.66e-05	CbGpPWpGaD
Ruxolitinib—JAK1—Signaling Pathways—IGF1—osteoarthritis	5.73e-05	6.64e-05	CbGpPWpGaD
Ruxolitinib—JAK2—Hemostasis—TGFB1—osteoarthritis	5.67e-05	6.57e-05	CbGpPWpGaD
Ruxolitinib—ROCK1—Signaling Pathways—IGF1—osteoarthritis	5.64e-05	6.53e-05	CbGpPWpGaD
Ruxolitinib—CYP3A4—Metabolism—FMOD—osteoarthritis	5.62e-05	6.51e-05	CbGpPWpGaD
Ruxolitinib—PRKCE—Immune System—IL6—osteoarthritis	5.52e-05	6.39e-05	CbGpPWpGaD
Ruxolitinib—BMPR2—Signaling Pathways—IL6—osteoarthritis	5.49e-05	6.37e-05	CbGpPWpGaD
Ruxolitinib—JAK2—Developmental Biology—TNF—osteoarthritis	5.4e-05	6.26e-05	CbGpPWpGaD
Ruxolitinib—JAK3—Signaling Pathways—CXCL8—osteoarthritis	5.36e-05	6.21e-05	CbGpPWpGaD
Ruxolitinib—IRAK1—Signaling Pathways—LEP—osteoarthritis	5.27e-05	6.11e-05	CbGpPWpGaD
Ruxolitinib—IRAK1—Innate Immune System—IL6—osteoarthritis	5.23e-05	6.06e-05	CbGpPWpGaD
Ruxolitinib—IRAK1—Immune System—IL1B—osteoarthritis	5.2e-05	6.03e-05	CbGpPWpGaD
Ruxolitinib—TYK2—Signaling Pathways—LEP—osteoarthritis	5.12e-05	5.94e-05	CbGpPWpGaD
Ruxolitinib—JAK3—Signaling by GPCR—IL6—osteoarthritis	5.09e-05	5.91e-05	CbGpPWpGaD
Ruxolitinib—PRKCE—Disease—IL6—osteoarthritis	5.09e-05	5.9e-05	CbGpPWpGaD
Ruxolitinib—TYK2—Innate Immune System—IL6—osteoarthritis	5.08e-05	5.88e-05	CbGpPWpGaD
Ruxolitinib—CAMK2G—Immune System—IL6—osteoarthritis	5.05e-05	5.86e-05	CbGpPWpGaD
Ruxolitinib—TYK2—Immune System—IL1B—osteoarthritis	5.05e-05	5.85e-05	CbGpPWpGaD
Ruxolitinib—IRAK1—Signaling Pathways—ESR1—osteoarthritis	5.04e-05	5.84e-05	CbGpPWpGaD
Ruxolitinib—JAK2—Signaling Pathways—MMP3—osteoarthritis	5.02e-05	5.81e-05	CbGpPWpGaD
Ruxolitinib—TYK2—Disease—PTGS2—osteoarthritis	5.01e-05	5.81e-05	CbGpPWpGaD
Ruxolitinib—IRAK1—Signaling Pathways—FN1—osteoarthritis	4.97e-05	5.77e-05	CbGpPWpGaD
Ruxolitinib—MAP3K7—Signaling Pathways—LEP—osteoarthritis	4.97e-05	5.76e-05	CbGpPWpGaD
Ruxolitinib—MAP3K3—Immune System—IL6—osteoarthritis	4.93e-05	5.72e-05	CbGpPWpGaD
Ruxolitinib—MAP3K7—Innate Immune System—IL6—osteoarthritis	4.92e-05	5.71e-05	CbGpPWpGaD
Ruxolitinib—JAK1—Disease—TGFB1—osteoarthritis	4.91e-05	5.69e-05	CbGpPWpGaD
Ruxolitinib—MAP3K7—Immune System—IL1B—osteoarthritis	4.9e-05	5.68e-05	CbGpPWpGaD
Ruxolitinib—TYK2—Signaling Pathways—ESR1—osteoarthritis	4.89e-05	5.67e-05	CbGpPWpGaD
Ruxolitinib—JAK3—Signaling Pathways—MMP9—osteoarthritis	4.85e-05	5.62e-05	CbGpPWpGaD
Ruxolitinib—TYK2—Signaling Pathways—FN1—osteoarthritis	4.83e-05	5.6e-05	CbGpPWpGaD
Ruxolitinib—JAK2—GPCR downstream signaling—CXCL8—osteoarthritis	4.81e-05	5.57e-05	CbGpPWpGaD
Ruxolitinib—MAP3K7—Signaling Pathways—ESR1—osteoarthritis	4.74e-05	5.5e-05	CbGpPWpGaD
Ruxolitinib—PRKCE—Signaling Pathways—TGFB1—osteoarthritis	4.73e-05	5.49e-05	CbGpPWpGaD
Ruxolitinib—MAP3K7—Signaling Pathways—FN1—osteoarthritis	4.68e-05	5.43e-05	CbGpPWpGaD
Ruxolitinib—JAK3—Immune System—IL6—osteoarthritis	4.66e-05	5.4e-05	CbGpPWpGaD
Ruxolitinib—JAK1—Signaling Pathways—CXCL8—osteoarthritis	4.61e-05	5.34e-05	CbGpPWpGaD
Ruxolitinib—CYP3A4—Metabolism—PTGES—osteoarthritis	4.58e-05	5.31e-05	CbGpPWpGaD
Ruxolitinib—JAK2—Signaling Pathways—SMAD3—osteoarthritis	4.54e-05	5.26e-05	CbGpPWpGaD
Ruxolitinib—ROCK1—Signaling Pathways—CXCL8—osteoarthritis	4.53e-05	5.25e-05	CbGpPWpGaD
Ruxolitinib—JAK1—Signaling by GPCR—IL6—osteoarthritis	4.38e-05	5.08e-05	CbGpPWpGaD
Ruxolitinib—JAK2—Signaling by GPCR—CXCL8—osteoarthritis	4.37e-05	5.06e-05	CbGpPWpGaD
Ruxolitinib—IRAK1—Signaling Pathways—IGF1—osteoarthritis	4.36e-05	5.05e-05	CbGpPWpGaD
Ruxolitinib—JAK2—Developmental Biology—IL6—osteoarthritis	4.36e-05	5.05e-05	CbGpPWpGaD
Ruxolitinib—ROCK1—Signaling by GPCR—IL6—osteoarthritis	4.31e-05	5e-05	CbGpPWpGaD
Ruxolitinib—TYK2—Signaling Pathways—IGF1—osteoarthritis	4.23e-05	4.9e-05	CbGpPWpGaD
Ruxolitinib—JAK1—Signaling Pathways—MMP9—osteoarthritis	4.17e-05	4.83e-05	CbGpPWpGaD
Ruxolitinib—MAP3K7—Signaling Pathways—IGF1—osteoarthritis	4.1e-05	4.76e-05	CbGpPWpGaD
Ruxolitinib—ROCK1—Signaling Pathways—MMP9—osteoarthritis	4.1e-05	4.75e-05	CbGpPWpGaD
Ruxolitinib—JAK1—Immune System—IL6—osteoarthritis	4e-05	4.64e-05	CbGpPWpGaD
Ruxolitinib—JAK3—Signaling Pathways—TGFB1—osteoarthritis	3.99e-05	4.63e-05	CbGpPWpGaD
Ruxolitinib—JAK2—Signaling Pathways—LEP—osteoarthritis	3.88e-05	4.5e-05	CbGpPWpGaD
Ruxolitinib—JAK2—Innate Immune System—IL6—osteoarthritis	3.85e-05	4.46e-05	CbGpPWpGaD
Ruxolitinib—JAK2—Immune System—IL1B—osteoarthritis	3.83e-05	4.44e-05	CbGpPWpGaD
Ruxolitinib—JAK2—Disease—PTGS2—osteoarthritis	3.8e-05	4.4e-05	CbGpPWpGaD
Ruxolitinib—JAK2—Signaling Pathways—ESR1—osteoarthritis	3.7e-05	4.29e-05	CbGpPWpGaD
Ruxolitinib—JAK1—Disease—IL6—osteoarthritis	3.7e-05	4.29e-05	CbGpPWpGaD
Ruxolitinib—JAK2—Signaling Pathways—FN1—osteoarthritis	3.66e-05	4.24e-05	CbGpPWpGaD
Ruxolitinib—TYK2—Disease—TGFB1—osteoarthritis	3.62e-05	4.2e-05	CbGpPWpGaD
Ruxolitinib—PRKCE—Signaling Pathways—IL6—osteoarthritis	3.57e-05	4.13e-05	CbGpPWpGaD
Ruxolitinib—IRAK1—Signaling Pathways—CXCL8—osteoarthritis	3.51e-05	4.06e-05	CbGpPWpGaD
Ruxolitinib—JAK1—Signaling Pathways—TGFB1—osteoarthritis	3.44e-05	3.98e-05	CbGpPWpGaD
Ruxolitinib—TYK2—Signaling Pathways—CXCL8—osteoarthritis	3.4e-05	3.94e-05	CbGpPWpGaD
Ruxolitinib—ROCK1—Signaling Pathways—TGFB1—osteoarthritis	3.38e-05	3.92e-05	CbGpPWpGaD
Ruxolitinib—MAP3K7—Signaling Pathways—CXCL8—osteoarthritis	3.3e-05	3.83e-05	CbGpPWpGaD
Ruxolitinib—TYK2—Signaling by GPCR—IL6—osteoarthritis	3.24e-05	3.75e-05	CbGpPWpGaD
Ruxolitinib—CYP3A4—Metabolism—GSTO1—osteoarthritis	3.23e-05	3.74e-05	CbGpPWpGaD
Ruxolitinib—JAK2—Signaling Pathways—IGF1—osteoarthritis	3.21e-05	3.72e-05	CbGpPWpGaD
Ruxolitinib—IRAK1—Signaling Pathways—MMP9—osteoarthritis	3.17e-05	3.67e-05	CbGpPWpGaD
Ruxolitinib—CYP3A4—Metabolism—BGN—osteoarthritis	3.13e-05	3.62e-05	CbGpPWpGaD
Ruxolitinib—TYK2—Signaling Pathways—MMP9—osteoarthritis	3.08e-05	3.57e-05	CbGpPWpGaD
Ruxolitinib—IRAK1—Immune System—IL6—osteoarthritis	3.05e-05	3.53e-05	CbGpPWpGaD
Ruxolitinib—JAK3—Signaling Pathways—IL6—osteoarthritis	3.01e-05	3.49e-05	CbGpPWpGaD
Ruxolitinib—MAP3K7—Signaling Pathways—MMP9—osteoarthritis	2.99e-05	3.46e-05	CbGpPWpGaD
Ruxolitinib—TYK2—Immune System—IL6—osteoarthritis	2.96e-05	3.43e-05	CbGpPWpGaD
Ruxolitinib—MAP3K7—Immune System—IL6—osteoarthritis	2.87e-05	3.32e-05	CbGpPWpGaD
Ruxolitinib—JAK2—Disease—TGFB1—osteoarthritis	2.75e-05	3.18e-05	CbGpPWpGaD
Ruxolitinib—TYK2—Disease—IL6—osteoarthritis	2.73e-05	3.16e-05	CbGpPWpGaD
Ruxolitinib—IRAK1—Signaling Pathways—TGFB1—osteoarthritis	2.61e-05	3.03e-05	CbGpPWpGaD
Ruxolitinib—JAK1—Signaling Pathways—IL6—osteoarthritis	2.59e-05	3e-05	CbGpPWpGaD
Ruxolitinib—JAK2—Signaling Pathways—CXCL8—osteoarthritis	2.58e-05	2.99e-05	CbGpPWpGaD
Ruxolitinib—ROCK1—Signaling Pathways—IL6—osteoarthritis	2.55e-05	2.95e-05	CbGpPWpGaD
Ruxolitinib—TYK2—Signaling Pathways—TGFB1—osteoarthritis	2.54e-05	2.94e-05	CbGpPWpGaD
Ruxolitinib—MAP3K7—Signaling Pathways—TGFB1—osteoarthritis	2.46e-05	2.85e-05	CbGpPWpGaD
Ruxolitinib—JAK2—Signaling by GPCR—IL6—osteoarthritis	2.45e-05	2.84e-05	CbGpPWpGaD
Ruxolitinib—JAK2—Signaling Pathways—MMP9—osteoarthritis	2.33e-05	2.7e-05	CbGpPWpGaD
Ruxolitinib—JAK2—Immune System—IL6—osteoarthritis	2.24e-05	2.6e-05	CbGpPWpGaD
Ruxolitinib—JAK2—Disease—IL6—osteoarthritis	2.07e-05	2.4e-05	CbGpPWpGaD
Ruxolitinib—IRAK1—Signaling Pathways—IL6—osteoarthritis	1.97e-05	2.28e-05	CbGpPWpGaD
Ruxolitinib—JAK2—Signaling Pathways—TGFB1—osteoarthritis	1.92e-05	2.23e-05	CbGpPWpGaD
Ruxolitinib—TYK2—Signaling Pathways—IL6—osteoarthritis	1.91e-05	2.22e-05	CbGpPWpGaD
Ruxolitinib—MAP3K7—Signaling Pathways—IL6—osteoarthritis	1.85e-05	2.15e-05	CbGpPWpGaD
Ruxolitinib—JAK2—Signaling Pathways—IL6—osteoarthritis	1.45e-05	1.68e-05	CbGpPWpGaD
Ruxolitinib—CYP3A4—Metabolism—PTGS2—osteoarthritis	8.99e-06	1.04e-05	CbGpPWpGaD
